Light Horse Therapeutics
San Diego, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $62M
Overview
A therapeutics company targeting genetic diseases and cancer with novel small molecule and RNA-based modalities.
RNA TherapeuticsGenetics & GenomicsOncology
Technology Platform
An integrated platform employing both small molecule and RNA-targeting strategies to drug genetically validated targets, including proteins and RNA transcripts involved in disease.
Funding History
1Total raised:$62M
Venture$62M
Opportunities
Its dual-modality approach provides flexibility to pursue the most druggable path for a wide array of genetically defined diseases, maximizing the pipeline's potential.
Risk Factors
Spreading focus across two distinct therapeutic modalities carries execution risk and requires deep expertise in both challenging technical areas.
Competitive Landscape
Operates in two competitive arenas: targeted small molecules and RNA therapeutics, requiring excellence in both chemistry and molecular biology to stand out.